当前位置: X-MOL 学术Lancet Diabetes Endocrinol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Correction to Lancet Diabetes Endocrinol 2019; 7: 855-65.
The Lancet Diabetes & Endocrinology ( IF 44.5 ) Pub Date : 2019-11-01 , DOI: 10.1016/s2213-8587(19)30322-5


Fleseriu M, Pivonello R, Elenkova A, et al. Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing's syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial. Lancet Diabetes Endocrinol 2019; 7: 855–65—In this Article, in the Study design and patients section of the Methods, 230 h should be 2300 h. In the Results section, 95% CI −10·7 to −0·79 should be nmol/L. Changes have been made for data alignment, figure axes, and addition to the key in figure 2. These corrections have been made to the online version as of Oct 15, 2019, and the printed version is correct.

中文翻译:

柳叶刀糖尿病内分泌校正2019; 7:855-65。

Fleseriu M,Pivonello R,Elenkova A等。左酮康唑治疗内源性库欣综合征(SONICS)的功效和安全性:3期,多中心,开放标签,单组试验。柳叶刀糖尿病内分泌2019; 7:855-65 —在本文中,在“方法的研究设计和患者”部分中,230小时应为2300小时。在“结果”部分中,95%CI -10·7至-0·79应为nmol / L。数据对齐方式,图形轴和图2中的键进行了更改。截至2019年10月15日,在线版本已进行了更正,并且印刷版本正确。
更新日期:2019-10-16
down
wechat
bug